Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Agrippal (2012/2013) in Adults and Elderly
NCT01636102Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of subunit inactivated influenza vaccine in influenza, sponsored by Novartis. Started Jul 2012; status: completed.
02
Drugs
subunit inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01636102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01636102.